Key Developments: Smith & Nephew PLC (SNN.N)

SNN.N on New York Stock Exchange

36.94USD
3 Aug 2015
Change (% chg)

$-0.07 (-0.19%)
Prev Close
$37.01
Open
$36.91
Day's High
$37.04
Day's Low
$36.64
Volume
184,007
Avg. Vol
95,282
52-wk High
$39.76
52-wk Low
$28.92

Search Stocks

Latest Key Developments (Source: Significant Developments)

Smith & Nephew plc reaffirms FY 2015 guidance; declares interim dividend
Thursday, 30 Jul 2015 

Smith & Nephew plc:Says that outlook for FY 2015 remains unchanged.Says that it continue to expect to deliver higher underlying revenue growth in FY 2015 than in FY 2014.Says interim dividend for the H1 2015 is 11.8¢ per share (23.6¢ per ADS), compared with 11.0¢ last year.The interim dividend will be paid on Oct. 27 to shareholders on the register at the close of business on Oct. 9.  Full Article

Biotec Pharmacon ends discussion about Woulgan distribution agreement with Smith & Nephew
Tuesday, 7 Jul 2015 

Biotec Pharmacon ASA:Biotec Pharmacon ASA and Smith & Nephew have mutually decided to end the discussion about a Woulgan distribution agreement.  Full Article

Smith & Nephew PLC to acquire Zimmer's Unicondylar Knee system in US market
Wednesday, 24 Jun 2015 

Smith & Nephew PLC:Says it acquires Zimmer Unicompartmental High Flex Knee system in the US market.Says terms of the transaction were not disclosed.Has purchased all existing inventory and certain intellectual property for the US market.Transaction will close within three business days after the merger between Zimmer and Biomet has closed.  Full Article

Smith & Nephew PLC receives $99 mln patent infringement payment from Arthrex
Wednesday, 17 Jun 2015 

Smith & Nephew PLC:Has received payment in connection with recent affirmation by U.S. Court of Appeals for Federal Circuit of $95 mln patent infringement judgment against Arthrex, Inc., (Naples, Fla).  Full Article

Smith & Nephew acquires interactive software technology to drive supply chain optimisation and improve savings for Syncera(tm) customers
Wednesday, 6 May 2015 

Smith & Nephew PLC:Says the acquisition of two software assets from S2 Interactive, a surgical software development company.Software applications acquired by Smith & Nephew are Virtual Backtable (VBT) and TrayTouch.Terms of the transaction were not disclosed.  Full Article

Smith & Nephew plc reaffirms FY 2015 outlook
Thursday, 30 Apr 2015 

Smith & Nephew plc:Says that outlook for FY 2015 remains unchanged.Says that it continue to expect to deliver higher underlying revenue growth in FY 2015 than in FY 2014.  Full Article

Smith & Nephew acquires Colombian Distributor
Tuesday, 3 Mar 2015 

Smith & Nephew plc:Announces the acquisition of EuroCiencia Colombia (ECC).ECC has been Smith & Nephew's sole distributor for orthopaedic reconstruction, trauma and sports medicine products in Colombia since 2006.The terms of the transaction have not been disclosed.  Full Article

Smith & Nephew plc acquires EuroCiencia Colombia
Tuesday, 3 Mar 2015 

Smith & Nephew plc:Acquires EuroCiencia Colombia.Says EuroCiencia Colombia has been Smith & Nephew's sole distributor for orthopaedic reconstruction, trauma and sports medicine products in Colombia since 2006.Terms of transaction have not been disclosed.  Full Article

Smith & Nephew Plc declares dividend
Thursday, 5 Feb 2015 

Smith & Nephew Plc:Says that a final dividend for 2014 of 18.6 US cents per ordinary share has been proposed.Says it will be payable, on May 6 to shareholders whose names appear on the register at the close of business on April 17.Says the ex-dividend date is April 16 and the final day for currency and dividend reinvestment plan elections is April 17.  Full Article

Smith & Nephew plc comments on FY 2015 revenue guidance
Thursday, 5 Feb 2015 

Smith & Nephew plc:expects the Group to deliver higher underlying revenue growth in FY 2015 than in FY 2014.  Full Article

Smith & Nephew posts earnings beat on knee, wound care growth

LONDON, July 30 - Smith & Nephew Plc, Europe's biggest maker of artificial hips and knees, beat market expectations with a 6 percent rise in first-half trading profit after growth accelerated in its knees implant and advanced wound care businesses.

Search Stocks